New York State Common Retirement Fund
AZN icon

New York State Common Retirement Fund’s AstraZeneca AZN Stock Holding History

New York State Common Retirement Fund’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.8M Sell
120,123
-21,292
-15% -$4M 0.03% 422
2026
Q1 		$27.9M Buy
141,415
+36,227
+34% +$6.99M 0.04% 337
2025
Q4 		$19.3M Sell
105,188
-53,173
-34% -$9.33M 0.03% 439
2025
Q3 		$24.3M Buy
158,361
+60,032
+61% +$9.09M 0.03% 385
2025
Q2 		$13.7M Buy
98,329
+30,650
+45% +$4.3M 0.02% 610
2025
Q1 		$9.95M Buy
67,679
+1,157
+2% +$167K 0.01% 718
2024
Q4 		$8.72M Buy
66,522
+4,562
+7% +$639K 0.01% 851
2024
Q3 		$9.65M Hold
61,960
– – 0.01% 801
2024
Q2 		$9.66M Buy
61,960
+32,313
+109% +$4.86M 0.01% 824
2024
Q1 		$4.02M Sell
29,647
-68,635
-70% -$9.09M 0.01% 1202
2023
Q4 		$13.2M Buy
98,282
+18,607
+23% +$2.42M 0.02% 706
2023
Q3 		$10.8M Buy
79,675
+43,797
+122% +$5.98M 0.02% 772
2023
Q2 		$5.14M Sell
35,878
-2,929
-8% -$431K 0.01% 1156
2023
Q1 		$5.39M Buy
38,807
+1,999
+5% +$269K 0.01% 1132
2022
Q4 		$4.99M Hold
36,808
– – 0.01% 1179
2022
Q3 		$4.04M Sell
36,808
-4,325
-11% -$549K 0.01% 1266
2022
Q2 		$5.43M Buy
41,133
+12,447
+43% +$1.63M 0.01% 1157
2022
Q1 		$3.81M Buy
28,686
+25,750
+877% +$3.09M ﹤0.01% 1412
2021
Q4 		$342K Hold
2,936
– – ﹤0.01% 2643
2021
Q3 		$353K Buy
2,936
+625
+27% +$72.8K ﹤0.01% 2655
2021
Q2 		$277K Buy
2,311
+929
+67% +$102K ﹤0.01% 2892
2021
Q1 		$137K Sell
1,382
-2,557
-65% -$257K ﹤0.01% 2973
2020
Q4 		$394K Buy
3,939
+951
+32% +$101K ﹤0.01% 2460
2020
Q3 		$327K Hold
2,988
– – ﹤0.01% 2427
2020
Q2 		$316K Buy
2,988
+726
+32% +$75K ﹤0.01% 2443
2020
Q1 		$202K Hold
2,262
– – ﹤0.01% 2454
2019
Q4 		$226K Buy
+2,262
New +$213K ﹤0.01% 2684
2017
Q4 		– Sell
-12,256
Closed -$830K – 3083
2017
Q3 		$830K Buy
+12,256
New +$774K ﹤0.01% 2097

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

New York State Common Retirement Fund's AZN Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its AstraZeneca (AZN) stake by 15% in Q2 2026, selling an estimated $4M and leaving 120,123 shares worth $22.8M. The position accounts for 0.03% of the portfolio, ranked #422.

New York State Common Retirement Fund first reported a position in AZN in Q3 2017 and has held it in 28 quarters since. The position peaked at $27.9M in Q1 2026. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • New York State Common Retirement Fund held 120,123 shares of AstraZeneca worth $22.8M as of Q2 2026.
  • New York State Common Retirement Fund sold 21,292 AstraZeneca shares in Q2 2026, an estimated $4M.
  • AstraZeneca made up 0.03% of New York State Common Retirement Fund's portfolio in Q2 2026, its #422 holding.
  • New York State Common Retirement Fund first reported a position in AstraZeneca in Q3 2017 and has held it in 28 quarters since.
  • New York State Common Retirement Fund's AstraZeneca position peaked at $27.9M in Q1 2026.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.